Published in AIDS on December 01, 1993
CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J Virol (1997) 1.88
Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol (1996) 1.80
Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39
Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol (1995) 1.28
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. J Virol (2002) 1.27
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology (2004) 1.26
RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol (1997) 1.23
Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol (1999) 1.23
Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. PLoS One (2007) 1.15
Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol (2000) 1.14
Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis. Proc Natl Acad Sci U S A (2005) 1.12
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. J Virol (2000) 1.10
High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol (1997) 1.09
Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms. J Immunol (1999) 1.03
Glut1-mediated glucose transport regulates HIV infection. Proc Natl Acad Sci U S A (2012) 1.02
CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor. J Virol (2000) 1.00
Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats. J Virol (1997) 0.99
HIV-1 replication and pathogenesis in the human thymus. Curr HIV Res (2003) 0.99
High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells. J Virol (1999) 0.95
Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. J Virol (2002) 0.91
Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy. J Virol (1999) 0.90
HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus. Rev Med Virol (1997) 0.89
Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus. Antimicrob Agents Chemother (2000) 0.89
Lentivirus-specific cytotoxic T-lymphocyte responses are rapidly lost in thymectomized cats infected with feline immunodeficiency virus. J Virol (2005) 0.86
Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes. J Virol (1997) 0.85
T-Cell Signaling in HIV-1 Infection. Open Virol J (2013) 0.83
Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes. J Virol (1998) 0.81
HIV-1 infection inhibits cytokine production in human thymic macrophages. Exp Hematol (2010) 0.80
Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes. J Virol (2009) 0.80
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice. Sci Rep (2015) 0.78
The enduring tale of T cells in HIV immunopathogenesis. Indian J Med Res (2013) 0.77
HIV infection of thymocytes inhibits IL-7 activity without altering CD127 expression. Retrovirology (2011) 0.76
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell (1986) 8.53
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem (1987) 3.13
Genetic engineering of ethanol production in Escherichia coli. Appl Environ Microbiol (1987) 3.06
Characterization of anaerobic fermentative growth of Bacillus subtilis: identification of fermentation end products and genes required for growth. J Bacteriol (1997) 2.35
Cloning and sequence analysis of the fermentative alcohol-dehydrogenase-encoding gene of Escherichia coli. Gene (1989) 2.04
Mutants of Escherichia coli deficient in the fermentative lactate dehydrogenase. J Bacteriol (1989) 2.03
Role of NAD in regulating the adhE gene of Escherichia coli. J Bacteriol (1996) 1.98
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
The ldhA gene encoding the fermentative lactate dehydrogenase of Escherichia coli. Microbiology (1997) 1.96
Prevention of breast tumour development in vivo by downregulation of the p185neu receptor. Nat Med (1995) 1.81
Hand problems in an accident and emergency department. J Hand Surg Br (1985) 1.79
Idiotypic mimicry of biological receptors. Annu Rev Immunol (1986) 1.78
Acetaldehyde coenzyme A dehydrogenase of Escherichia coli. J Bacteriol (1980) 1.78
Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A (1985) 1.70
Anaerobically induced genes of Escherichia coli. J Bacteriol (1986) 1.67
A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J Virol (1994) 1.65
The use of suicide substrates to select mutants of Escherichia coli lacking enzymes of alcohol fermentation. Mol Gen Genet (1986) 1.64
Mutation of the ptsG gene results in increased production of succinate in fermentation of glucose by Escherichia coli. Appl Environ Microbiol (2001) 1.50
Altered phospholipid composition in mutants of Escherichia coli sensitive or resistant to organic solvents. J Gen Microbiol (1979) 1.50
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect Immun (1998) 1.48
Accumulation of trehalose by Escherichia coli K-12 at high osmotic pressure depends on the presence of amber suppressors. J Bacteriol (1988) 1.44
Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci U S A (1986) 1.43
Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect Immun (2000) 1.43
Isolation and genetic analysis of mutations allowing the degradation of furans and thiophenes by Escherichia coli. J Bacteriol (1987) 1.38
Facial hypertrophic scarring from pulsed dye laser. Dermatol Surg (1998) 1.38
Anaerobic regulation of the adhE gene, encoding the fermentative alcohol dehydrogenase of Escherichia coli. J Bacteriol (1993) 1.38
Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD program. JAMA (1999) 1.37
Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A (1985) 1.34
Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med (1985) 1.34
Escherichia coli derivatives lacking both alcohol dehydrogenase and phosphotransacetylase grow anaerobically by lactate fermentation. J Bacteriol (1989) 1.31
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun (1997) 1.26
Syngeneic monoclonal internal image anti-idiotopes as prophylactic vaccines. J Immunol (1986) 1.26
Protein tyrosine phosphorylation associated with activation of the interleukin 2 receptor. J Biol Chem (1990) 1.24
Anaerobic fermentation balance of Escherichia coli as observed by in vivo nuclear magnetic resonance spectroscopy. J Bacteriol (1989) 1.22
Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br J Cancer (2007) 1.22
Proton suicide: general method for direct selection of sugar transport- and fermentation-defective mutants. J Bacteriol (1984) 1.20
Beta-hydroxydecanoyl thio ester dehydrase does not catalyze a rate-limiting step in Escherichia coli unsaturated fatty acid synthesis. Biochemistry (1983) 1.16
A novel fermentation pathway in an Escherichia coli mutant producing succinic acid, acetic acid, and ethanol. Appl Biochem Biotechnol (1998) 1.15
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol (1993) 1.14
Molecular cloning and sequence of the thdF gene, which is involved in thiophene and furan oxidation by Escherichia coli. J Bacteriol (1991) 1.14
A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS (1998) 1.14
T4 endocytosis and phosphorylation induced by phorbol esters but not by mitogen or HIV infection. J Immunol (1988) 1.12
Cryptosporidium parvum infection requires host cell actin polymerization. Infect Immun (2001) 1.12
Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens. J Immunol (1986) 1.12
Mutant of Escherichia coli deficient in osmoregulation of periplasmic oligosaccharide synthesis. J Bacteriol (1985) 1.09
IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. J Immunol (1991) 1.07
Regulation of the ldhA gene, encoding the fermentative lactate dehydrogenase of Escherichia coli. Microbiology (2001) 1.07
Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest (1999) 1.06
Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein. J Virol (1999) 1.04
Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol (1991) 1.02
Chronic arteriovenous shunt: evaluation of a model for heart failure in rat. Am J Physiol (1979) 1.01
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res (1999) 1.00
Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg (1997) 1.00
Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules. Proc Natl Acad Sci U S A (1990) 0.99
Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope. J Immunol (1987) 0.98
HIV-1 and the thymus. AIDS (1997) 0.98
A case of human myiasis caused by Phormia regina (Diptera: Calliphoridae) in Missouri, USA. J Med Entomol (1986) 0.97
Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol (1988) 0.95
The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J Biol Chem (1993) 0.95
Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cells. J Biol Chem (1993) 0.94
Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice. Diabetologia (1985) 0.93
Locations of genes in the nar-adhE region of the Escherichia coli K-12 chromosome. J Bacteriol (1991) 0.93
Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody. J Immunol (1986) 0.90
Detection of avian oncovirus group-specific antigens by the enzyme-linked immunosorbent assay. J Gen Virol (1980) 0.90
Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptor. Clin Immunol Immunopathol (1985) 0.90
Cardiovascular response to acute aquatic and treadmill exercise in the untrained rat. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.90
Aerobic activity of Escherichia coli alcohol dehydrogenase is determined by a single amino acid. J Bacteriol (2000) 0.89
Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness. J Exp Med (1990) 0.88
Anaerobic growth defects resulting from gene fusions affecting succinyl-CoA synthetase in Escherichia coli K12. Mol Gen Genet (1989) 0.87
Interleukin 2-dependent phosphorylation of interleukin 2 receptors and other T cell membrane proteins. J Immunol (1986) 0.87
Effects of velocity modulation during surgical needle insertion. Conf Proc IEEE Eng Med Biol Soc (2005) 0.87
Thiophene-degrading Escherichia coli mutants possess sulfone oxidase activity and show altered resistance to sulfur-containing antibiotics. Appl Environ Microbiol (1990) 0.87
Pathogenesis of cerebral infarction and hemorrhage induced by a murine leukemia virus. Lab Invest (1994) 0.87
Subacute cutaneous lupus erythematosus presenting as erythroderma. J Am Acad Dermatol (1988) 0.87
Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines. Leukemia (2000) 0.86
Inhibitors of the polymerase chain reaction in Papanicolaou stain. Removal with a simple destaining procedure. Acta Cytol (1996) 0.84
Human neonatal thymic organ culture: an ex vivo model of thymocyte ontogeny and HIV-1 infection. Pathobiology (1994) 0.84
Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells. Virology (1994) 0.84
Analysis and molecular cloning of genes involved in thiophene and furan oxidation by E. coli. Appl Biochem Biotechnol (1990) 0.83
Bacterial mutants for the study of lipid metabolism. Methods Enzymol (1981) 0.83
The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection. Transplantation (1985) 0.82
A novel RNase G mutant that is defective in degradation of adhE mRNA but proficient in the processing of 16S rRNA precursor. Biochem Biophys Res Commun (2001) 0.82
AI/LEARN: an interactive videodisk system for teaching medical concepts and reasoning. J Med Syst (1987) 0.82
Comparison of the fermentative alcohol dehydrogenases of Salmonella typhimurium and Escherichia coli. Microbios (2000) 0.81
Construction and properties of pyruvate dehydrogenase complexes with up to nine lipoyl domains per lipoate acetyltransferase chain. FEMS Microbiol Lett (1992) 0.80
Diminished tyrosine protein kinase activity in T cells unresponsive to TCR stimulation. J Leukoc Biol (1994) 0.80
Specific infection of central nervous system white matter by a variant of gross murine leukemia virus. Virology (1990) 0.80
Initial characterization of a polyclonal antibody to an insulin-sensitive glycophospholipid. Arch Biochem Biophys (1988) 0.80
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery (1999) 0.79
Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn Mol Pathol (2001) 0.79
Acetaldehyde dehydrogenase activity of the AdhE protein of Escherichia coli is inhibited by intermediates in ubiquinone synthesis. FEMS Microbiol Lett (2000) 0.79
Effect of chelating agents and respiratory inhibitors on regulation of the cadA gene in Escherichia coli. Arch Microbiol (1997) 0.79
Thyroid-derived epithelial cells acquire alloantigen-presenting capabilities following X-irradiation and class II antigen induction. Eur J Immunol (1990) 0.79
Anti-idiotypic antibodies as probes of cell surface receptors. Mol Cell Biochem (1984) 0.79
Receptor systems in tissues of the nervous system. Immunol Rev (1987) 0.78
Mutations permitting the anaerobic growth of Escherichia coli on trehalose. FEMS Microbiol Lett (1991) 0.78
The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines. Exp Hematol (2000) 0.78
Molecular biology of drug resistance. Breast Cancer Res Treat (1987) 0.77